financing
Nuevocor Raises $45 Million in Series B Funding Round
The funds will support a Phase I/II trial of its gene therapy candidate in an aggressive form of dilated cardiomyopathy due to LMNA gene mutations.
Haya Therapeutics Raises $65M in Series A Funds to Develop Noncoding RNA-Targeted Drugs
The firm develops RNA-guided therapeutics that target the regulatory genome, composed of genes that regulate expression of other genes.
Liquid Biopsy Firm QCDx Closes $7M Financing Round
The proceeds will be used to launch a new diagnostic instrument, a breast cancer monitoring assay, and proprietary multiplex immunofluorescence reagent kits.
Craif Raises $22M in Series C Round to Expand US, Japan Operations
The Nagoya University spinout will open an office in San Diego and is working toward FDA approval of its miSignal early cancer detection test.
Alcyone Therapeutics Gets Funding, Batten Disease Gene Therapy From Nationwide Children's Hospital
The biotech and hospital have expanded their collaboration, with Alcyone now advancing a gene therapy for Batten disease that the hospital was developing.
Mar 27, 2025
Genomic Data Analytics Firm Galatea Bio Raises $25M
Feb 10, 2025
Mustang Bio Closes $8M Public Offering
Jan 29, 2025
Quibim Raises $50M in Series A Financing
Jan 8, 2025
XyloCor Raises $67.5M in Series B Financing
Dec 30, 2024